Coulthard, L R <br/><br/>
Differential effects of infliximab on absolute circulating blood leucocyte counts of innate immune cells in early and late rheumatoid arthritis patients.  [electronic resource] 

 -  Clinical and experimental immunology  Oct 2012 
 - 36-46 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2249 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2249.2012.04626.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal--administration & dosage<br/>Antirheumatic Agents--therapeutic use<br/>Arthritis, Rheumatoid--immunology<br/>B-Lymphocytes--drug effects<br/>CD4-Positive T-Lymphocytes--drug effects<br/>CD8-Positive T-Lymphocytes--drug effects<br/>Case-Control Studies<br/>Disease Progression<br/>Drug Therapy, Combination<br/>Female<br/>Flow Cytometry<br/>GPI-Linked Proteins--immunology<br/>Granulocytes--drug effects<br/>Humans<br/>Infliximab<br/>Leukocyte Count<br/>Leukocytes--drug effects<br/>Lipopolysaccharide Receptors--immunology<br/>Male<br/>Methotrexate--administration & dosage<br/>Methylprednisolone--therapeutic use<br/>Middle Aged<br/>Monocytes--drug effects<br/>Receptors, IgG--immunology<br/>Tumor Necrosis Factor-alpha--therapeutic use